Synonyms | HY-18204 SPBio_001260 4997-EP2301936A1 KBio2_007423 SR-05000001928-1
AB0013966 L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI) VA11929 AC1L1U1M MLS000759423 Valsartan (JP17/USAN/INN) AN-7255 N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE Valsartan, United States Pharmacopeia (USP) Reference Standard BIDD:GT0345 ZINC3875259 CEPA brand of valsartan (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid D00400 (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid DS-1248 NSC758927 137862-53-4 GTPL593 s1894 4997-EP2277879A1 4997-EP2298772A1 J-007068 Spectrum3_001831 4997-EP2308839A1 KBioSS_002289 Tareg AB00639940_09 Lacer brand of valsartan Vals ACWBQPMHZXGDFX-QFIPXVFZSA-N MolPort-003-666-608 Valsartan [USAN:INN] AX8018200 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine Valtan (TN) BRD-K45158365-001-05-6 CHEBI:9927 (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Exforge Prexxartan (oral solution) 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid HMS2093K22 SBI-0206738.P001 HMS3715P12 Schwarz brand of valsartan 4997-EP2301923A1 KBio2_002287 Spectrum_001796 62V534 L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)- UNII-80M03YXJ7I AB2000354 MFCD00865840 valsartan (Diovan) AKOS015994698 N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine Valsartan, European Pharmacopoeia (EP) Reference Standard BDBM50049186 N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine Varexan CCG-101028 (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid CPD000466318 (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid Diovan (TN) Novartis brand of valsartan (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine GP8514 RTR-031794 4997-EP2270011A1 4997-EP2295406A1 I14-41498 SPECTRUM1505209 4997-EP2305219A1 KBio3_003006 ST2408288 AB00639940-06 L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- VAL-489 AC1Q5QIK MLS001424088 Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard ANW-49040 N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine Valsartan,(S) BR-58790 [3H]valsartan CGP 48933 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid. D04HSR (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid EC 604-045-2 Pharmakon1600-01505209 137863-60-6 HMS1922L21 SAM001246581 SC-00971 4997-EP2298776A1 J10013 Spectrum4_000749 KS-00000ISS TL8000869 AB00639940_11 LS-161334 Valsarran AK-58790 N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine Valsartan [USAN:USP:INN:BAN] BC204156 N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine Valzaar BSPBio_003501 (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid DB00177 NC00278 (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine EZR-104 Provas 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid HMS2232F05 HSDB 7519 SMR000466318 4997-EP2301931A1 KBio2_004855 SR-05000001928 80M03YXJ7I L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- V-120 AC-4543 Miten Valsartan (JAN/USAN/INN) AM90287 N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material BG0645 walsartan CCG-221275 (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid CS-1967 (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid Diovan, Valsartan NSC-758927 (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine GTPL3937 S-6418 4997-EP2272841A1 4997-EP2295422A2 I997 Spectrum2_001120 4997-EP2308562A2 KBioGR_001078 SW197658-2 AB00639940-08 L-Valsartan Valpression ACT02671 MolPort-002-507-854 Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard Aventis brand of valsartan N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine Valtan BRD-K45158365-001-02-3 CGP-48933 (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid D06UDG N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid Esteve brand of valsartan Prexxartan 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid HMS2051L12 Sanol brand of valsartan HMS3651E04 SCHEMBL2542 4997-EP2298779A1 Kalpress Spectrum5_001582 KS-1194 TR-031794 AB07510 MCULE-6728882368 AKOS015914315 N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine Valsartan, >=98% (HPLC) BCP05184 N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine Valzaar (TN) C24H29N5O3 (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid CHEMBL1069 (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid Diovan Nisis (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine FT-0631156 PubChem9865 [ Show all ] |
---|
Inchi ID | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
---|